Pfizer Vaccines LLC
8Patents
8Active
8Granted
44Portfolio score
Filing activity: Dec 9, 2009 → Sep 15, 2016 · 1 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9216229B2 | IgE CH3 peptide vaccine | Human Necessities | 7 | Active |
| US8889144B2 | PCSK9 vaccine | Chemistry; Metallurgy | 5 | Active |
| US8298547B2 | IgE CH3 peptide vaccine | Human Necessities | 4 | Active |
| US8722053B2 | IgE CH3 peptide vaccine | Emerging Cross-Sectional Technologies | 3 | Active |
| US8475801B2 | IgE CH3 peptide vaccine | Human Necessities | 1 | Active |
| US9987341B2 | PCSK9 vaccine | Chemistry; Metallurgy | 0 | Active |
| US9481875B2 | PCSK9 vaccine | Chemistry; Metallurgy | 0 | Active |
| US9249233B2 | IgE CH3 peptide vaccine | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.